1) Wilson, C. P. et al. 2012. Riboflavin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT genotype: a 4-y follow-up. Am J Clin Nutr.95(3):766-72. doi: 10.3945/ajcn.111.026245.
2) Wilson, C. P. et al. 2013. Blood pressure in treated hypertensive individuals with the MTHFR 677TT genotype is responsive to intervention with riboflavin: findings of a targeted randomized trial. Hypertension. 61(6):1302-8. doi: 10.1161/HYPERTENSIONAHA.111.01047.
3) Boehnke, C. et al. 2004. High-dose riboflavin treatment is efficacious in migraine prophylaxis:an open study in a tertiary care. European Journal of Neurology. 11: 475–477.
4) Namazi, N. et al. 2015. Supplementation with Riboflavin (Vitamin B2) for Migraine Prophylaxis in Adults and Children: A Review. International Journal for Vitamin and Nutrition Research. 85(1-2):79–87.
5) Olteanu, H. Munson, T. Banerjee, R. 2002. Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry. 41(45):13378-85. .
6) Wilson, A. et al. 1999. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab. (4):317-23.
7) Seibold, P. et al. Polymorphisms in oxidative stress-related genes and postmenopausal breast cancer risk. Int J Cancer. 129(6):1467-76.
8) Jiang-Hua, Q. et al. 2014. Association of methylenetetrahydrofolate reductase and methionine synthase polymorphisms with breast cancer risk and interaction with folate, vitamin B6, and vitamin B 12 intakes. Tumour Biol. 35(12):11895-901.
Referenzen Interaktionen
Stargrove, M. B. et al. Herb, Nutrient and Drug Interactions: Clinical Implications and Therapeutic Strategies, 1. Auflage. St. Louis, Missouri: Elsevier Health Sciences, 2008.
Gröber, U. Mikronährstoffe: Metabolic Tuning –Prävention –Therapie, 3. Auflage. Stuttgart: WVG Wissenschaftliche Verlagsgesellschaft Stuttgart, 2011.
Gröber, U. Arzneimittel und Mikronährstoffe: Medikationsorientierte Supplementierung, 3. aktualisierte und erweiterte Auflage. Stuttgart: WVG Wissenschaftliche Verlagsgesellschaft Stuttgart, 2014.
|